EUA
Genetrack SARS-CoV-2 Molecular Assay
FDA Emergency Use Authorization · Genetrack Biolabs, Inc. · Feb 16, 2023
Key facts
| Product | Genetrack SARS-CoV-2 Molecular Assay |
|---|---|
| Company | Genetrack Biolabs, Inc. |
| Product type | Real-time RT-PCR, Home Collection, Multiple Targets |
| Date | Feb 16, 2023 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: